Member Exclusive

Gene therapy trial for Duchenne muscular dystrophy put on hold by FDA

Gene therapy, SGT-001, to treat Duchenne muscular dystrophy halted by the FDA after second patient experiences serious adverse event.

Go to the profile of Alexander Marshall
Nov 13, 2019
0
0

Please sign in or register for FREE

No comments yet.